title: Behçet's disease and cardiac arrhythmia.
abstract: Only few cases of cardiac conduction disturbances and arrhythmias have been reported in Behçet's disease. We recently observed the case of a 16-year-old woman with Behçet's disease in whom cardiac arrhythmia became the main clinical symptom. This observation and a review of the literature led us to the conclusion that arrhythmia could represent the clinical manifestation of an underlying myocarditis due to Behçet's disease and can be regarded as a feature of cardiac involvement of the disease.
authors.affiliation: Institute of Internal Medicine and Geriatrics, Catholic University, Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Mirone
authors.forename: L
authors.initials: L
authors.lastname: Altomonte
authors.forename: E M
authors.initials: EM
authors.lastname: Ferlisi
authors.forename: A
authors.initials: A
authors.lastname: Zoli
authors.forename: M
authors.initials: M
authors.lastname: Magaró
mesh_terms: D000293:Adolescent; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005260:Female; D006801:Humans; D011405:Propafenone / Q000008:administration & dosage / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D013617:Tachycardia, Supraventricular / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000889:Anti-Arrhythmia Agents; D011405:Propafenone